eGlint
PrivateLast Round
Seed
Nov 1, 2021
Total Funding Raised
$2.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
eGlint operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Seed round in November 2021.
eGlint is a biotechnology company that develops ProteoNex, a rapid, multiplexed proteomics platform designed for real-time biomarker measurement from blood samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eGlint Comparables
Compare eGlint with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nomic Bio | 77% | |
| Alamar Biosciences | 73% | |
| Standard BioTools | 71% |
For institutional investors. Book with your work email.
eGlint Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
eGlint Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Seed |
| Breakthrough Energy Ventures | Seed |
| Lakestar | Seed |
| Ulu Ventures | Seed |
| SeedFolio | Seed |
| Emerald Bioventures | Seed |
| Half Court Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 975% MoM, reaching 1.7K.
- May 15, 2026
Monthly visitors grew 65% MoM, from 763 to 1.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 19, 2026
eGlint, Inc. is named the 2026 BioTools Innovator Grand Prize Winner and receives the $250,000 top award at the BioTools Innovator Capstone Competition in California on Oct 14th '26 after live audience voting selects it from four finalists.
- identified_as_competitor_ofOct 19, 2026
In the BioTools Arena, eGlint is identified as a competitor of Pando Bioscience, alongside Caravel and QuantumCyte.
- receives_awardOct 19, 2026
At the BioTools Innovator Capstone Competition in California on Oct 14th '26, eGlint, Inc. receives the 2026 BioTools Innovator Grand Prize for its breakthrough in rapid, distributed proteomics.
- receives_awardOct 15, 2026
eGlint, Inc. receives the $250,000 Grand Prize from BioTools Innovator at its 2026 Capstone Event in California on Oct 15th '26, selected by a live audience of industry leaders.
- receives_financingOct 15, 2026
eGlint, Inc. receives the $250K Grand Prize from BioTools Innovator on Oct 15th '26 in California to advance its proteomics platform.
For institutional investors. Book with your work email.
eGlint Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about eGlint's valuation, stock price, and market status.
Is eGlint a public or private company?
eGlint is a private company.
What is the current stock price of eGlint?
eGlint is a private company, so its shares have no public market price. Caplight tracks eGlint's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is eGlint worth (valuation)?
Valuation information for eGlint is not publicly available.
Can I buy eGlint stock?
eGlint shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was eGlint's last funding round?
eGlint's most recent funding round was Seed on November 1, 2021.
Who are the main investors in eGlint?
Key investors in eGlint include MedTech Innovator, Breakthrough Energy Ventures, Lakestar, Ulu Ventures, SeedFolio.
Will eGlint IPO soon?
No public IPO plans have been announced for eGlint.
How can I track eGlint secondary market activity?
Caplight tracks bids, offers, and trades in eGlint's shares on secondary markets.